Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 208449
Company: ZYDUS PHARMS
Company: ZYDUS PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET;ORAL | Discontinued | None | No | No |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 2.5MG;850MG | TABLET;ORAL | Discontinued | None | No | No |
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 2.5MG;1GM | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
03/30/2023 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208449Orig1s000TALtr.pdf |